| (+)-catechin | multiple interactions | ISO | RGD:1313694 | 6480464 | Catechin inhibits the reaction [S100B protein results in increased expression of ITGB2 mRNA] | CTD | PMID:17103373 |
| (S)-ropivacaine | multiple interactions | ISO | RGD:1313694 | 6480464 | ropivacaine inhibits the reaction [TNF protein results in increased expression of [ITGAM protein binds to ITGB2 protein]] | CTD | PMID:9336308 |
| 1-naphthyl isothiocyanate | increases response to substance | ISO | RGD:1313695 | 6480464 | ITGB2 protein results in increased susceptibility to 1-Naphthylisothiocyanate | CTD | PMID:16614373 |
| 1-naphthyl isothiocyanate | increases response to substance | ISO | RGD:1313695 | 6480464 | ITGB2 protein results in increased susceptibility to 1-Naphthylisothiocyanate | CTD | PMID:16614373 PMID:21070799 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1313695 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ITGB2 mRNA | CTD | PMID:16962184 |
| 2-nitrotoluene | increases expression | EXP | | 6480464 | 2-nitrotoluene results in increased expression of ITGB2 mRNA | CTD | PMID:16460773 |
| 5-azacytidine | decreases expression | ISO | RGD:1313694 | 6480464 | Azacitidine results in decreased expression of ITGB2 mRNA | CTD | PMID:19194470 |
| 5-fluorouracil | decreases expression | ISO | RGD:1313694 | 6480464 | Fluorouracil results in decreased expression of ITGB2 | CTD | PMID:15485462 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:1313694 | 6480464 | Dimethyl Sulfoxide promotes the reaction [alitretinoin results in increased expression of ITGB2 protein] | CTD | PMID:15964820 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:1313694 | 6480464 | Aspirin results in decreased expression of [ITGA2B protein binds to ITGB2 protein] | CTD | PMID:15140583 |
| acrolein | increases expression | ISO | RGD:1313695 | 6480464 | Acrolein results in increased expression of ITGB2 mRNA | CTD | PMID:18515264 |
| aflatoxin B1 | decreases expression | ISO | RGD:1313694 | 6480464 | Aflatoxin B1 results in decreased expression of ITGB2 mRNA | CTD | PMID:22100608 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1313694 | 6480464 | Tretinoin results in increased expression of ITGB2 protein | CTD | PMID:18055984 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1313694 | 6480464 | Tretinoin results in increased expression of ITGB2 mRNA | CTD | PMID:15498508 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:1313694 | 6480464 | Tretinoin results in increased expression of ITGB2 mRNA | CTD | PMID:16581781 more ... |
| all-trans-retinoic acid | increases expression | ISO | RGD:1313694 | 6480464 | Tretinoin results in increased expression of ITGB2 mRNA | CTD | PMID:15498508 more ... |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1313694 | 6480464 | CSF3 protein promotes the reaction [Tretinoin results in increased expression of ITGB2 protein] | CTD | PMID:18055984 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1313694 | 6480464 | EP300 protein promotes the reaction [Tretinoin results in increased expression of ITGB2 mRNA]; more ... | CTD | PMID:16581781 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1313694 | 6480464 | Tretinoin results in increased expression of ITGB2 mRNA | CTD | PMID:16322068 PMID:16581781 |
| asbestos | decreases expression | ISO | RGD:1313694 | 6480464 | Asbestos results in decreased expression of ITGB2 mRNA | CTD | PMID:22398240 |
| benzene | decreases expression | ISO | RGD:1313694 | 6480464 | Benzene results in decreased expression of ITGB2 mRNA | CTD | PMID:20036648 |
| benzo[a]pyrene | increases expression | ISO | RGD:1313695 | 6480464 | Benzo(a)pyrene results in increased expression of ITGB2 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:1313694 | 6480464 | Benzo(a)pyrene results in increased expression of ITGB2 mRNA | CTD | PMID:22316170 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1313695 | 6480464 | Mustard Gas results in increased expression of ITGB2 mRNA | CTD | PMID:18955075 |
| bisphenol A | increases expression | ISO | RGD:1313694 | 6480464 | bisphenol A results in increased expression of ITGB2 mRNA; more ... | CTD | PMID:14555285 |
| bromochloroacetic acid | increases expression | EXP | | 6480464 | bromochloroacetic acid results in increased expression of ITGB2 mRNA | CTD | PMID:16460773 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of ITGB2 promoter | CTD | PMID:22457795 |
| choline | multiple interactions | ISO | RGD:1313695 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB2 mRNA | CTD | PMID:20938992 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ITGB2 mRNA | CTD | PMID:22023808 |
| diarsenic trioxide | increases expression | ISO | RGD:1313694 | 6480464 | arsenic trioxide results in increased expression of ITGB2 mRNA | CTD | PMID:20458559 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:1313694 | 6480464 | Dimethyl Sulfoxide promotes the reaction [alitretinoin results in increased expression of ITGB2 protein] | CTD | PMID:15964820 |
| folic acid | multiple interactions | ISO | RGD:1313695 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB2 mRNA | CTD | PMID:20938992 |
| griseofulvin | affects expression | ISO | RGD:1313695 | 6480464 | Griseofulvin affects the expression of ITGB2 mRNA | CTD | PMID:12735108 |
| hydroquinone | decreases expression | ISO | RGD:1313695 | 6480464 | hydroquinone results in decreased expression of ITGB2 protein | CTD | PMID:17464197 |
| hydroquinone | increases expression | ISO | RGD:1313695 | 6480464 | hydroquinone results in increased expression of ITGB2 protein | CTD | PMID:21664406 |
| indomethacin | multiple interactions | ISO | RGD:1313695 | 6480464 | Indomethacin results in increased expression of [ITGAM protein binds to ITGB2 protein] | CTD | PMID:10761979 |
| indomethacin | affects response to substance | ISO | RGD:1313695 | 6480464 | ITGB2 protein affects the susceptibility to Indomethacin | CTD | PMID:10486359 |
| iron atom | increases expression | ISO | RGD:1313694 | 6480464 | Iron deficiency results in increased expression of ITGB2 mRNA | CTD | PMID:20368581 |
| isotretinoin | increases expression | ISO | RGD:1313694 | 6480464 | Isotretinoin results in increased expression of ITGB2 mRNA | CTD | PMID:20436886 |
| L-methionine | multiple interactions | ISO | RGD:1313695 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB2 mRNA | CTD | PMID:20938992 |
| leukotriene B4 | increases expression | EXP | | 6480464 | Leukotriene B4 results in increased expression of ITGB2 protein | CTD | PMID:14716214 |
| lidocaine | multiple interactions | ISO | RGD:1313694 | 6480464 | Lidocaine inhibits the reaction [TNF protein results in increased expression of [ITGAM protein binds to ITGB2 protein]] | CTD | PMID:9336308 |
| LY294002 | multiple interactions | ISO | RGD:1313694 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein] | CTD | PMID:16963453 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | increases expression | ISO | RGD:1313694 | 6480464 | N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein | CTD | PMID:10215738 PMID:16393473 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | increases expression | ISO | RGD:1313695 | 6480464 | N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein | CTD | PMID:21664406 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | multiple interactions | ISO | RGD:1313694 | 6480464 | plaunotol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein] | CTD | PMID:10215738 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | increases expression | ISO | RGD:1313694 | 6480464 | N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein | CTD | PMID:10215738 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | multiple interactions | ISO | RGD:1313694 | 6480464 | crenatoside inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; more ... | CTD | PMID:16393473 |
| nitric oxide | multiple interactions | ISO | RGD:1313694 | 6480464 | Nitric Oxide promotes the reaction [ITGB2 protein results in increased activity of RAP1A protein]; more ... | CTD | PMID:16963453 |
| nitric oxide | increases abundance | EXP | | 6480464 | ITGB2 protein results in increased abundance of Nitric Oxide | CTD | PMID:8600936 |
| nitric oxide | multiple interactions | EXP | | 6480464 | CSF2 protein promotes the reaction [ITGB2 protein results in increased abundance of Nitric Oxide]; more ... | CTD | PMID:8600936 |
| ozone | increases response to substance | EXP | | 6480464 | ITGB2 protein results in increased susceptibility to Ozone | CTD | PMID:8600936 |
| ozone | multiple interactions | EXP | | 6480464 | [ITGB2 protein results in increased susceptibility to Ozone] which results in increased abundance of Nitric Oxide; more ... | CTD | PMID:8600936 |
| paracetamol | affects expression | ISO | RGD:1313695 | 6480464 | Acetaminophen affects the expression of ITGB2 mRNA | CTD | PMID:17562736 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1313694 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein | CTD | PMID:16393473 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1313694 | 6480464 | crenatoside inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]; more ... | CTD | PMID:16393473 |
| pirinixic acid | multiple interactions | ISO | RGD:1313694 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ITGB2 mRNA | CTD | PMID:19710929 |
| pirinixic acid | decreases expression | ISO | RGD:1313695 | 6480464 | pirinixic acid results in decreased expression of ITGB2 mRNA | CTD | PMID:17426115 |
| plaunotol | multiple interactions | ISO | RGD:1313694 | 6480464 | plaunotol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein] | CTD | PMID:10215738 |
| progesterone | affects expression | ISO | RGD:1313695 | 6480464 | Progesterone affects the expression of ITGB2 mRNA | CTD | PMID:17251523 |
| quercetin | multiple interactions | ISO | RGD:1313694 | 6480464 | Quercetin inhibits the reaction [S100B protein results in increased expression of ITGB2 mRNA] | CTD | PMID:17103373 |
| resveratrol | multiple interactions | ISO | RGD:1313694 | 6480464 | resveratrol analog inhibits the reaction [formylmethionyl-leucyl-phenylalanine methyl ester results in increased expression of ITGB2 protein] | CTD | PMID:9605577 |
| simvastatin | affects binding | ISO | RGD:1313694 | 6480464 | Simvastatin binds to [ITGAL protein binds to ITGB2 protein] | CTD | PMID:15041742 |
| simvastatin | decreases expression | ISO | RGD:1313694 | 6480464 | Simvastatin results in decreased expression of ITGB2 mRNA | CTD | PMID:12615677 |
| simvastatin | multiple interactions | ISO | RGD:1313694 | 6480464 | Simvastatin inhibits the reaction [TNF results in increased expression of ITGB2] | CTD | PMID:12615677 |
| simvastatin | multiple interactions | ISO | RGD:1313695 | 6480464 | Simvastatin results in decreased expression of [ITGAM protein binds to ITGB2 protein] | CTD | PMID:21330348 |
| staurosporine | multiple interactions | ISO | RGD:1313694 | 6480464 | Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein] | CTD | PMID:16393473 |
| streptozocin | multiple interactions | EXP | | 6480464 | KLK1 protein inhibits the reaction [Streptozocin results in increased expression of ITGB2 protein] | CTD | PMID:16129698 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of ITGB2 protein | CTD | PMID:16129698 |
| sulfasalazine | multiple interactions | ISO | RGD:1313694 | 6480464 | Sulfasalazine inhibits the reaction [TNF protein results in increased expression of ITGB2 protein] | CTD | PMID:8094364 |
| tamibarotene | increases expression | ISO | RGD:1313694 | 6480464 | Am 80 results in increased expression of ITGB2 mRNA; more ... | CTD | PMID:15498508 |
| tetrachloromethane | increases expression | ISO | RGD:1313695 | 6480464 | Carbon Tetrachloride results in increased expression of ITGB2 mRNA | CTD | PMID:15056808 |
| theophylline | increases expression | ISO | RGD:1313694 | 6480464 | Theophylline results in increased expression of ITGB2 mRNA | CTD | PMID:16083514 |
| trans-resveratrol | multiple interactions | ISO | RGD:1313694 | 6480464 | resveratrol analog inhibits the reaction [formylmethionyl-leucyl-phenylalanine methyl ester results in increased expression of ITGB2 protein] | CTD | PMID:9605577 |
| triphenylstannane | increases expression | ISO | RGD:1313694 | 6480464 | triphenyltin results in increased expression of ITGB2 mRNA; more ... | CTD | PMID:12788061 |
| wortmannin | multiple interactions | ISO | RGD:1313694 | 6480464 | wortmannin inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein] | CTD | PMID:16963453 |
| zinc atom | decreases expression | ISO | RGD:1313694 | 6480464 | Zinc results in decreased expression of ITGB2 mRNA | CTD | PMID:19071009 |
| zinc(0) | decreases expression | ISO | RGD:1313694 | 6480464 | Zinc results in decreased expression of ITGB2 mRNA | CTD | PMID:19071009 |